These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3340477)
1. Early and late surfactant treatments in baboon model of hyaline membrane disease. Maeta H; Vidyasagar D; Raju TN; Bhat R; Matsuda H Pediatrics; 1988 Feb; 81(2):277-83. PubMed ID: 3340477 [TBL] [Abstract][Full Text] [Related]
2. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease. Vidyasagar D; Maeta H; Raju TN; John E; Bhat R; Go M; Dahiya U; Roberson Y; Yamin A; Narula A Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883 [TBL] [Abstract][Full Text] [Related]
3. Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease. Shimada S; Raju TN; Bhat R; Maeta H; Vidyasagar D Pediatr Res; 1989 Dec; 26(6):565-9. PubMed ID: 2602035 [TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Gitlin JD; Soll RF; Parad RB; Horbar JD; Feldman HA; Lucey JF; Taeusch HW Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835 [TBL] [Abstract][Full Text] [Related]
5. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML; Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of severe hyaline membrane disease with a single-dose of natural exogenous surfactant of porcine origin. A randomized trial: immediate effects and outcome at 28 days of life]. Walti H; Relier JP; Huon C; Monset-Couchard M; Scemama M; De Gamarra E; Moriette G; Curstedt T; Robertson B Arch Fr Pediatr; 1990 May; 47(5):329-34. PubMed ID: 2196030 [TBL] [Abstract][Full Text] [Related]
7. Role of early postnatal dexamethasone in respiratory distress syndrome. Mukhopadhyay K; Kumar P; Narang A Indian Pediatr; 1998 Feb; 35(2):117-22. PubMed ID: 9707853 [TBL] [Abstract][Full Text] [Related]
8. Ventilatory management of infant baboons with hyaline membrane disease: the use of high frequency ventilation. Delemos RA; Coalson JJ; Gerstmann DR; Null DM; Ackerman NB; Escobedo MB; Robotham JL; Kuehl TJ Pediatr Res; 1987 Jun; 21(6):594-602. PubMed ID: 3299231 [TBL] [Abstract][Full Text] [Related]
9. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Kwong MS; Egan EA; Notter RH; Shapiro DL Pediatrics; 1985 Oct; 76(4):585-92. PubMed ID: 3900906 [TBL] [Abstract][Full Text] [Related]
10. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. Couser RJ; Ferrara TB; Ebert J; Hoekstra RE; Fangman JJ J Pediatr; 1990 Jan; 116(1):119-24. PubMed ID: 2404097 [TBL] [Abstract][Full Text] [Related]
11. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods. Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505 [TBL] [Abstract][Full Text] [Related]
13. Reduced incidence of hyaline membrane disease in extremely premature infants following delay of delivery in mother with preterm labor: use of ritodrine and betamethasone. Kwong MS; Egan EA Pediatrics; 1986 Nov; 78(5):767-74. PubMed ID: 3532016 [TBL] [Abstract][Full Text] [Related]
14. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome. Teksam O; Kale G Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732 [TBL] [Abstract][Full Text] [Related]
15. Delayed extubation to nasal continuous positive airway pressure in the immature baboon model of bronchopulmonary dysplasia: lung clinical and pathological findings. Thomson MA; Yoder BA; Winter VT; Giavedoni L; Chang LY; Coalson JJ Pediatrics; 2006 Nov; 118(5):2038-50. PubMed ID: 17079577 [TBL] [Abstract][Full Text] [Related]
16. Asphyxia and hyaline membrane disease in neonatal monkeys. Hessler JR; Mantilla G; Kirkpatrick BV; Donnelly WH; Cassin S; Eitzman DV Am J Perinatol; 1985 Apr; 2(2):101-7. PubMed ID: 3854275 [TBL] [Abstract][Full Text] [Related]
17. Surfactant replacement therapy in utero for prevention of hyaline membrane disease in the preterm baboon. Galan HL; Cipriani C; Coalson JJ; Bean JD; Collier G; Kuehl TJ Am J Obstet Gynecol; 1993 Oct; 169(4):817-24. PubMed ID: 8238135 [TBL] [Abstract][Full Text] [Related]
18. Response to bovine surfactant (surfactant TA) in two different HMD models (lambs and baboons). Maeta H; Vidyasagar D; Raju T; Bhat R; Matsuda H Eur J Pediatr; 1988 Feb; 147(2):162-7. PubMed ID: 3366133 [TBL] [Abstract][Full Text] [Related]